• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Indication of Surgical Hepatectomy for the Patients of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombosis.外科肝切除术治疗下腔静脉肿瘤血栓形成的肝细胞癌患者的适应证。
Kobe J Med Sci. 2021 Jun 18;67(1):E10-E17.
2
Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: a new classification for surgical guidance.外科治疗伴有下腔静脉癌栓的肝细胞癌:一种新的外科指导分类。
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):263-9. doi: 10.1016/s1499-3872(13)60043-0.
3
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.肝细胞癌伴下腔静脉或右心房癌栓的外科治疗。
World J Surg Oncol. 2013 Oct 5;11:259. doi: 10.1186/1477-7819-11-259.
4
Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis.肝细胞癌合并肝静脉癌栓的外科治疗。
J Hepatol. 2014 Sep;61(3):583-8. doi: 10.1016/j.jhep.2014.04.032. Epub 2014 May 4.
5
Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases.复发性肝细胞癌合并下腔静脉、右心房和膈静脉血栓切除术:三例报告。
World J Surg Oncol. 2020 Jun 22;18(1):138. doi: 10.1186/s12957-020-01914-8.
6
Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus.机器人辅助腹腔镜联合胸腔镜治疗肝癌合并下腔静脉癌栓。
Ann Surg Oncol. 2023 Sep;30(9):5447-5449. doi: 10.1245/s10434-023-13512-5. Epub 2023 Jun 7.
7
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
8
Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.在伴有腔静脉和肝脏侵犯的晚期肾上腺恶性肿瘤肝切除术中,采用不同寻常的技术来保证手术和肿瘤学安全性。
Ann Surg Oncol. 2018 Oct;25(11):3324-3325. doi: 10.1245/s10434-018-6657-5. Epub 2018 Jul 17.
9
Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and/or thrombosis.伴有下腔静脉侵犯和/或血栓形成的肝细胞癌手术切除的治疗结果
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1694-9. doi: 10.5754/hge10653. Epub 2011 Jul 15.
10
Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis.粒子放疗(一种新型外照射放疗)与肝切除术治疗伴有下腔静脉瘤栓的肝细胞癌:配对分析
Surgery. 2017 Dec;162(6):1241-1249. doi: 10.1016/j.surg.2017.08.006. Epub 2017 Oct 12.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.乐伐替尼与索拉非尼用于不可切除肝细胞癌患者一线治疗的比较:一项随机、III 期非劣效性试验。
Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1.
3
Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.伴有下腔静脉或右心房癌栓的肝细胞癌手术治疗结果
Surg Today. 2018 Sep;48(9):819-824. doi: 10.1007/s00595-017-1619-2. Epub 2017 Dec 26.
4
Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis.粒子放疗(一种新型外照射放疗)与肝切除术治疗伴有下腔静脉瘤栓的肝细胞癌:配对分析
Surgery. 2017 Dec;162(6):1241-1249. doi: 10.1016/j.surg.2017.08.006. Epub 2017 Oct 12.
5
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey.肝切除术治疗伴有肝静脉侵犯的肝细胞癌:一项日本全国性调查。
Hepatology. 2017 Aug;66(2):510-517. doi: 10.1002/hep.29225. Epub 2017 Jun 26.
6
Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis.肝细胞癌合并肝静脉癌栓的外科治疗。
J Hepatol. 2014 Sep;61(3):583-8. doi: 10.1016/j.jhep.2014.04.032. Epub 2014 May 4.
7
Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma.多次双侧肝细胞癌行肝叶切除术联合序贯经皮孤立肝灌注的长期疗效和预后因素。
Ann Surg Oncol. 2014 Mar;21(3):971-8. doi: 10.1245/s10434-013-3305-y. Epub 2013 Nov 8.
8
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.肝细胞癌伴下腔静脉或右心房癌栓的外科治疗。
World J Surg Oncol. 2013 Oct 5;11:259. doi: 10.1186/1477-7819-11-259.
9
Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study.手术治疗下腔静脉/右心房癌栓肝癌的生存获益:一项回顾性队列研究的结果。
Ann Surg Oncol. 2013 Mar;20(3):914-22. doi: 10.1245/s10434-012-2646-2. Epub 2012 Sep 7.
10
Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion.肝细胞癌侵犯下腔静脉/心脏的临床特征和治疗结局。
Anticancer Res. 2011 Dec;31(12):4641-6.

外科肝切除术治疗下腔静脉肿瘤血栓形成的肝细胞癌患者的适应证。

Indication of Surgical Hepatectomy for the Patients of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombosis.

机构信息

Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

Kobe J Med Sci. 2021 Jun 18;67(1):E10-E17.

PMID:34344853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8622260/
Abstract

The prognosis of hepatocellular carcinoma (HCC) presenting with inferior vena cava tumor thrombus (IVCTT) is extremely poor. The aim of this study was to reveal the postoperative course and to identify patients who have survived surgical hepatectomy among HCC patients with IVCTT. Between January 2006 and December 2018, 643 patients underwent surgical hepatectomy for HCC at Kobe University Hospital. Among them, 20 patients were categorized as Vv3 according to the Japanese staging system. We retrospectively collected detailed data on these patients. The statistical, clinical, and pathological data were recorded prospectively and analyzed retrospectively. The median survival time was 9.8 months. Among all patients, 11 (55%) achieved R0 resection, and only two survivors were from this group. The number of tumors (solitary vs. multiple; p=0.050) and pathological Vp (pVp0 vs. other; p=0.009) were identified as risk factors for overall survival in the univariate analysis. In the multivariate analysis, pathological Vp (pVp0 vs. other; p=0.037) was identified as a significant prognostic factor for survival. Pathological Vp affected overall survival among IVCTT patients; the median survival time was 53.7 months with pVp0, 10.2 months with pVp1, and 8.8 months with pVp2-4 (p=0.035). For patients with IVCTT, surgical hepatectomy should be indicated only for those who do not have portal vein invasion and could achieve R0 resection.

摘要

肝细胞癌(HCC)伴下腔静脉癌栓(IVCTT)的预后极差。本研究旨在揭示术后过程,并确定 HCC 伴 IVCTT 患者中接受手术肝切除后存活的患者。2006 年 1 月至 2018 年 12 月,神户大学医院共有 643 例 HCC 患者接受手术肝切除。其中,20 例患者根据日本分期系统分为 Vv3 期。我们回顾性收集了这些患者的详细资料。统计、临床和病理数据前瞻性收集并回顾性分析。中位生存时间为 9.8 个月。所有患者中,11 例(55%)达到 R0 切除,只有 2 例存活者来自该组。肿瘤数量(单发与多发;p=0.050)和病理 Vp(pVp0 与其他;p=0.009)在单因素分析中被确定为总生存的危险因素。在多因素分析中,病理 Vp(pVp0 与其他;p=0.037)被确定为生存的显著预后因素。病理 Vp 影响 IVCTT 患者的总生存;pVp0 的中位生存时间为 53.7 个月,pVp1 为 10.2 个月,pVp2-4 为 8.8 个月(p=0.035)。对于 IVCTT 患者,只有无门静脉侵犯且能达到 R0 切除的患者才应行手术肝切除。